| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |